Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia

Pullarkat, V; Pratz, KW; D&#246;hner, H; Recher, C; Thirman, MJ; DiNardo, CD; Fenaux, P; Schuh, AC; Wei, AH; Pigneux, A; Jang, JH; Juliusson, G; Miyazaki, Y; Selleslag, D; Arellano, ML; Liu, C; Ridgeway, JA; Potluri, J; Schuler, J; Konopleva, M

Author(s): Pullarkat, V; Pratz, KW; Döhner, H; Recher, C; Thirman, MJ; DiNardo, CD; Fenaux, P; Schuh, AC; Wei, AH; Pigneux, A; Jang, JH; Juliusson, G; Miyazaki, Y; Selleslag, D; Arellano, ML; Liu, C; Ridgeway, JA; Potluri, J; Schuler, J; Konopleva, M;
Details: Publication Year 2025-03-28,Volume 15,Issue #1,Page 49
Journal Title: Blood Cancer Journal
Publisher: Springer Nature
Research Division(s): Blood Cells And Blood Cancer
PubMed ID: 40155601
Publisher's Version: https://doi.org/10.1038/s41408-025-01263-3
Open Access at Publisher's Site: https://doi.org/10.1038/s41408-025-01263-3
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2025-04-08 03:06:04

Last Modified: 2025-04-08 03:12:24